Alexander Send, PhD

Comparison of Safety and Tolerability of Deutetrabenazine During Titration and Maintenance in Patients With Tardive Dyskinesia

Background: Deutetrabenazine is approved to treat tardive dyskinesia (TD) in adults and is titrated weekly based on dyskinesia control and tolerability. This analysis compared the safety ...

Nayla Chaijale , PhD;

Alexander Send , PhD;

Juha-Matti Savola , MD, PhD;

Mark Forrest Gordon , MD;

Amanda Wilhelm , PhD;

Karen Anderson , MD;

Hubert Fernandez , MD;

Hadas Barkay , PhD;

10/08/2020

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Alexander Send, PhD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products